文献速递肝病

非酒精性脂肪性肝炎亚型的代谢组学鉴定

Metabolomic Identification of Subtypes of Nonalcoholic Steatohepatitis.
PubMed 文献 · Gastroenterology · 2017-01-26

研究通过MAT1A基因敲除小鼠及535例活检证实的非酒精性脂肪性肝病(NAFLD)患者(单纯性脂肪变性353例、非酒精性脂肪性肝炎(NASH)182例)的血清代谢组分析,发现一种与MAT1A-KO小鼠相关的血清代谢特征存在于49%的患者中,据此识别出2种NAFLD亚型,并鉴定出各亚型中区分NASH与单纯性脂肪变性的标志物组合;MAT1A-KO小鼠给予SAMe(30 mg/kg/天,共8周)可减轻脂肪性肝炎特征。

要点

  • 在535例活检证实的NAFLD患者中识别出2种主要NAFLD亚型
  • 一种与MAT1A-KO小鼠相关的血清代谢特征存在于49%的患者中
  • 各亚型均有可区分NASH与单纯性脂肪变性的标志物组合

核心结论

  • 在NAFLD患者与MAT1A-KO小鼠的血清代谢组分析中识别出2种主要NAFLD亚型及各亚型中区分脂肪变性与NASH的标志物,这些标志物可能用于监测疾病进展和识别治疗靶点。

研究设计与样本

  • 研究收集MAT1A-KO小鼠(肝脏S-腺苷甲硫氨酸(SAMe)水平长期低下并自发发生脂肪性肝炎)及C57Bl/6对照小鼠的肝脏和血清并测定代谢组。
  • 研究分析535例活检证实的NAFLD患者(单纯性脂肪变性353例、NASH 182例)的血清代谢组,并与小鼠血清代谢组比较。
  • MAT1A-KO小鼠给予SAMe(30 mg/kg/天,共8周),收集肝脏样本进行组织学分析以评估脂肪性肝炎。

主要发现

  • MAT1A-KO小鼠肝脏表现为甘油三酯、甘油二酯、脂肪酸、神经酰胺和氧化脂肪酸水平高,SAMe及其下游代谢物水平低。
  • 肝脏与血清代谢组之间存在相关性。
  • 识别出与MAT1A-KO小鼠相关的血清代谢特征,该特征也存在于49%的患者中,并据此识别出2种NAFLD亚型。
  • 针对每种NAFLD亚型,识别出可区分NASH患者与单纯性脂肪变性患者的具体标志物组合。
  • 给予SAMe可减轻MAT1A-KO小鼠的脂肪性肝炎特征。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Nonalcoholic fatty liver disease (NAFLD) is a consequence of defects in diverse metabolic pathways that involve hepatic accumulation of triglycerides. Features of these aberrations might determine whether NAFLD progresses to nonalcoholic steatohepatitis (NASH). We investigated whether the diverse defects observed in patients with NAFLD are caused by different NAFLD subtypes with specific serum metabolomic profiles, and whether these can distinguish patients with NASH from patients with simple steatosis. METHODS: We collected liver and serum from methionine adenosyltransferase 1a knockout (MAT1A-KO) mice, which have chronically low levels of hepatic S-adenosylmethionine (SAMe) and spontaneously develop steatohepatitis, as well as C57Bl/6 mice (controls); the metabolomes of all samples were determined. We also analyzed serum metabolomes of 535 patients with biopsy-proven NAFLD (353 with simple steatosis and 182 with NASH) and compared them with serum metabolomes of mice. MAT1A-KO mice were also given SAMe (30 mg/kg/day for 8 weeks); liver samples were collected and analyzed histologically for steatohepatitis. RESULTS: Livers of MAT1A-KO mice were characterized by high levels of triglycerides, diglycerides, fatty acids, ceramides, and oxidized fatty acids, as well as low levels of SAMe and downstream metabolites. There was a correlation between liver and serum metabolomes. We identified a serum metabolomic signature associated with MAT1A-KO mice that also was present in 49% of the patients; based on this signature, we identified 2 NAFLD subtypes. We identified specific panels of markers that could distinguish patients with NASH from patients with simple steatosis for each subtype of NAFLD. Administration of SAMe reduced features of steatohepatitis in MAT1A-KO mice. CONCLUSIONS: In an analysis of serum metabolomes of patients with NAFLD and MAT1A-KO mice with steatohepatitis, we identified 2 major subtypes of NAFLD and markers that differentiate steatosis from NASH in each subtype. These might be used to monitor disease progression and identify therapeutic targets for patients.

来源:Gastroenterology,查看原文。版权归原作者所有。

引用

  1. Alonso C, Fernández-Ramos D, Varela-Rey M, et al. Metabolomic Identification of Subtypes of Nonalcoholic Steatohepatitis. Gastroenterology. 2017. PMID: 28132890. doi:10.1053/j.gastro.2017.01.015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。